[
    [
        {
            "time": "2021-06-24",
            "original_text": "“抗疫”概念股迎利好 华大基因新冠突变株检测产品获欧盟准入",
            "features": {
                "keywords": [
                    "华大基因",
                    "新冠突变株检测",
                    "欧盟准入",
                    "CE资质"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "“抗疫”概念股迎利好 华大基因新冠突变株检测产品获欧盟准入",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-24",
            "original_text": "华大基因(300676.SZ)子公司新冠核酸检测产品获得CE准入资质",
            "features": {
                "keywords": [
                    "华大基因",
                    "新冠核酸检测",
                    "CE准入资质"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "华大基因(300676.SZ)子公司新冠核酸检测产品获得CE准入资质",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-24",
            "original_text": "华大基因：截至目前，公司三项新冠突变株检测产品获得了欧盟CE准入资质",
            "features": {
                "keywords": [
                    "华大基因",
                    "新冠突变株检测",
                    "欧盟CE准入资质"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "华大基因：截至目前，公司三项新冠突变株检测产品获得了欧盟CE准入资质",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-24",
            "original_text": "医疗器械深度报告-伴随诊断系列报告之二：核心技术突破不断 伴随诊断迎高速发展期",
            "features": {
                "keywords": [
                    "医疗器械",
                    "伴随诊断",
                    "核心技术突破",
                    "高速发展期"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗器械深度报告-伴随诊断系列报告之二：核心技术突破不断 伴随诊断迎高速发展期",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]